Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_assertion type Assertion NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_head.
- NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_assertion wasGeneratedBy ECO_0000203 NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_provenance.
- NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_assertion wasDerivedFrom befree-2016 NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_provenance.
- NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_assertion SIO_000772 12468567 NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_provenance.
- NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_assertion evidence source_evidence_literature NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_provenance.
- NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_assertion description "[ECE inhibitor treatment also reduced cardiac fibrosis, tissue factor expression, left ventricular basic fibroblast growth factor mRNA levels, and immunostaining in the vessel wall, independent of high blood pressure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376717.RA_QRCMwoV6JlUVA1_qmFmrakJMvk2nn0aK3avue9lNzM130_provenance.